2024-12-01 2025-11-30 false Capium Accounts Production 1.1 12338180 2024-12-01 2025-11-30 12338180 bus:FullAccounts 2024-12-01 2025-11-30 12338180 bus:FRS102 2024-12-01 2025-11-30 12338180 bus:AuditExemptWithAccountantsReport 2024-12-01 2025-11-30 12338180 bus:SmallCompaniesRegimeForAccounts 2024-12-01 2025-11-30 12338180 bus:PrivateLimitedCompanyLtd 2024-12-01 2025-11-30 12338180 2024-12-01 2025-11-30 12338180 2025-11-30 12338180 bus:RegisteredOffice 2024-12-01 2025-11-30 12338180 core:WithinOneYear 2025-11-30 12338180 core:AfterOneYear 2025-11-30 12338180 1 2024-12-01 2025-11-30 12338180 bus:Director1 2024-12-01 2025-11-30 12338180 bus:Director1 2025-11-30 12338180 bus:Director1 2023-12-01 2024-11-30 12338180 2023-12-01 12338180 bus:LeadAgentIfApplicable 2024-12-01 2025-11-30 12338180 2023-12-01 2024-11-30 12338180 2024-11-30 12338180 core:WithinOneYear 2024-11-30 12338180 core:AfterOneYear 2024-11-30 12338180 bus:EntityAccountantsOrAuditors 2023-12-01 2024-11-30 12338180 core:ComputerEquipment 2024-12-01 2025-11-30 12338180 core:ComputerEquipment 2025-11-30 12338180 core:ComputerEquipment 2024-11-30 12338180 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-11-30 12338180 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2024-11-30 12338180 core:CostValuation core:Non-currentFinancialInstruments 2025-11-30 12338180 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 12338180 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-11-30 12338180 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 12338180 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-11-30 12338180 core:Non-currentFinancialInstruments 2025-11-30 12338180 core:Non-currentFinancialInstruments 2024-11-30 12338180 core:ShareCapital 2025-11-30 12338180 core:ShareCapital 2024-11-30 12338180 core:RetainedEarningsAccumulatedLosses 2025-11-30 12338180 core:RetainedEarningsAccumulatedLosses 2024-11-30 12338180 dpl:Item1 2024-12-01 12338180 dpl:Item1 2025-11-30 12338180 dpl:Item1 2023-12-01 12338180 dpl:Item1 2024-11-30 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 12338180
England and Wales
EJA MEDICAL LTD
Unaudited Financial Statements
Period of accounts Start date: 01 December 2024 End date: 30 November 2025

Eja Medical Ltd Contents Page For the year ended 30 November 2025
Company information | 1
Accountants' report | 2
Statement of financial position | 3
Notes to the financial statements | 4

Eja Medical Ltd Company Information For the year ended 30 November 2025
Director | Mouri ISLAM
Registered Number | 12338180
Registered Office | 93 Goresbrook Road Dagenham RM9 6YG
Accountants | ASR Accountancy Ltd 18 Barking Road East Ham London E6 3BP
1

Eja Medical Ltd Accountants' Report For the year ended 30 November 2025
Accountant’s report You consider that the company is exempt from an audit for the year ended 30 November 2025 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. ASR Accountancy Ltd 30 November 2025 .................................................... ASR Accountancy Ltd 18 Barking Road East Ham London E6 3BP 02 April 2026 2

Eja Medical Ltd Statement of Financial Position As at 30 November 2025
| Notes | 2025 £ |  | 2024 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 1 |  | 1
|  | 1 |  | 1
Current assets |  |  |
Debtors | 4 | 0 |  | 9,915
Cash at bank and in hand |  | 383 |  | 2
|  | 383 |  | 9,917
Creditors: amount falling due within one year | 5 | (338) |  | (6,313)
Net current assets |  | 45 |  | 3,604
Total assets less current liabilities |  | 46 |  | 3,605
Creditors: amount falling due after more than one year | 6 | (11,299) |  | (14,743)
Net assets |  | (11,253) |  | (11,138)
Capital and reserves |  |  |
Called up share capital |  | 2 |  | 2
Profit and loss account |  | (11,255) |  | (11,140)
Shareholders' funds |  | (11,253) |  | (11,138)
For the year ended 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The financial statements were approved by the director on 02 April 2026 and were signed by:
------------------------------- Mouri ISLAM Director
3

Eja Medical Ltd Notes to the Financial Statements For the year ended 30 November 2025
General Information Eja Medical Ltd is a private company, limited by shares, registered in England and Wales, registration number 12338180, registration address 93 Goresbrook Road, Dagenham, RM9 6YG. The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Finance lease and hire purchase charges The finance element of the rental payment is charged to the income statement on a straight line basis. Taxation Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Current and deferred tax assets and liabilities are not discounted Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost less depreciation. Depreciation is provided at rates calculated to write off the cost of fixed assets over their expected useful lives on the following basis:
Computer Equipment | 3 Straight Line
2. | Average number of employees Average number of employees during the year was 1 (2024 : 1).
3. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 December 2024 | 799 |  | 799
Additions | - |  | -
Disposals | - |  | -
At 30 November 2025 | 799 |  | 799
Depreciation
At 01 December 2024 | 798 |  | 798
Charge for year | - |  | -
On disposals | - |  | -
At 30 November 2025 | 798 |  | 798
Net book values
Closing balance as at 30 November 2025 | 1 |  | 1
Opening balance as at 01 December 2024 | 1 |  | 1
4. | Debtors: amounts falling due after one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Directors Loan Accounts | 0 |  | 966
Directors' Loan Accounts | 0 |  | 8,949
| 0 |  | 9,915
5. | Creditors: amount falling due within one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Corporation Tax | 0 |  | 5,975
Directors' Current Accounts | 338 |  | 338
| 338 |  | 6,313
6. | Creditors: amount falling due after more than one year
| 2025 £ |  | 2024 £
--- | --- | --- | ---
Hire Purchase | 11,299 |  | 14,743
| 11,299 |  | 14,743
4